Inovio Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INO research report →
Companywww.inovio.com
Inovio Pharmaceuticals, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.
- CEO
- Jacqueline E. Shea
- IPO
- 1998
- Employees
- 134
- HQ
- Plymouth Meeting, PA, US
Price Chart
Valuation
- Market Cap
- $66.72M
- P/E
- -10.13
- P/S
- 0.00
- P/B
- 141.78
- EV/EBITDA
- -0.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -666.47%
- ROIC
- -567.11%
Growth & Income
- Revenue
- $65.34K · -69.99%
- Net Income
- $-84,945,901 · 20.80%
- EPS
- $-1.81 · 54.18%
- Op Income
- $-86,822,104
- FCF YoY
- 14.97%
Performance & Tape
- 52W High
- $2.98
- 52W Low
- $1.03
- 50D MA
- $1.35
- 200D MA
- $1.86
- Beta
- 1.44
- Avg Volume
- 2.50M
Get TickerSpark's AI analysis on INO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Shea Jacqueline Elizabeth | other | 17,744 |
| May 15, 26 | Shea Jacqueline Elizabeth | other | 7,717 |
| May 15, 26 | Shea Jacqueline Elizabeth | other | 17,744 |
| May 15, 26 | KIES PETER | other | 4,771 |
| May 15, 26 | KIES PETER | other | 2,571 |
| May 15, 26 | KIES PETER | other | 4,771 |
| May 15, 26 | Humeau Laurent | other | 4,771 |
| May 15, 26 | Humeau Laurent | other | 1,712 |
| May 15, 26 | Humeau Laurent | other | 4,771 |
| May 15, 26 | Sumner Michael John | other | 2,385 |
Our INO Coverage
We haven't published any research on INO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INO Report →